SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Company Profile
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Key Executives
| Name | Position |
|---|---|
| Patrick H. Mooney | CEO & Director |
| James Robert Dennewill Jr. | Chief Operating Officer |
| Jean-Frederic Viret | Chief Financial Officer |
| Chetan Pujara | Chief Research & Development Officer |
| Glenn Sussman | Co-founder & Chief Technology Advisor |
| Malik Y. Kahook | Co-Founder, President, Chief Medical Officer & Executive Chairman |
| Mike Pinder | Vice President of Marketing |
| Paul Yoo | Senior Vice President of Clinical Development |
| Rachel Gilette | Vice President of Human Resources |
| Shannon Trevino | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 01, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| May 14, 2026 | 10-Q | Quarterly Report |
| May 14, 2026 | 8-K | Current Report |
| Mar 26, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 09, 2026 | 8-K | Current Report |
| Feb 17, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 17, 2026 | SC 13D | Filing |
SpyGlass Pharma Inc. Common Stock
| Country | United States |
| IPO Date | Feb 6, 2026 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Patrick H. Mooney |
Contact Details
15326 Alton Parkway Irvine,
California 92618 United States
Stock Details
| Ticker Symbol | SGP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001778922 |
| CUSIP Number | 85220G109 |
| ISIN Number | US85220G1094 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove SGP